PHARMACEUTICAL COMPOSITION FOR CO-ADMINISTRATION OF ANTICANCER DRUG

WIPO Patent Application WO/2020/213939

A1

The present invention pertains to a pharmaceutical composition for the co-administration of an anticancer drug. In addition to the anticancer drug, the pharmaceutical composition preferably further contains an aldehyde inhibitor, and more preferably, an aldehyde inhibitor and a biguanide-based compound, but is not limited to. This pharmaceutical composition is highly effective in killing not only cancer cells but also cancer stem cells, and is thus expected to be widely used for cancer treatment in the fields of medicine and health.

WO/2018/213587	ANTICANCER TRAIL-TARGETED PLANT VIRUS PARTICLES
JP2003531138	INDUSTRIAL APPLICABILITY N-substituted dithiocarbamate for the treatment of biological diseases.
JP4361733	In vitro amplification method of viral nucleic acid and in vitro destruction method of tumor cells by performing the amplification method

KIM HONG YEOUL (KR)

PCT/KR2020/005065

October 22, 2020

April 16, 2020

Click for automatic bibliography generation  

GINXEN CO LTD (KR)

A61K31/704; A61K31/155; A61K31/4184; A61K31/506; A61K31/555; A61K33/242; A61K45/06; A61P35/00

KR20180045884A	2018-05-04
KR20150102152A	2015-09-07
KR20160094861A	2016-08-10
KR101900478B1	2018-09-20
KR20200005906A	2020-01-17

KANG, J. H. ET AL.: "Aldehyde dehydrogenase inhibition combined with phenformin treatment reversed NSCLC through ATP depletion", ONCOTARGET, vol. 7, no. 31, 2016, pages 49397 - 49410, XP055559244, DOI: 10.18632/oncotarget.10354

LEE, Jae Young (KR)

View/Download PDF      PDF Help

Previous Patent: PHARMACEUTICAL COMPOSITION FOR TREATING CANCER COMPRISING SAPONIN AS ACTIVE INGREDIENT

Next Patent: SHOWER TOWEL SET EQUIPPED WITH HOLDER